当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析

前沿生物-U

(688221)

  

流通市值:38.43亿  总市值:38.43亿
流通股本:3.75亿   总股本:3.75亿

前沿生物-U(688221)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.44亿元,每股收益-0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益109721.14万元,未分配利润-200060.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产172374.28万元,负债62653.14万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入28,328,182.53129,472,935.9891,643,894.3951,056,036.51
营业总成本74,909,155.77405,686,029.6282,018,728.06185,196,329.54
营业利润-44,136,120.43-201,093,560.92-193,195,084.43-160,209,310.16
利润总额-44,121,517.41-201,382,610.39-193,457,754.17-160,459,078.15
净利润-44,121,517.41-201,382,610.39-193,457,754.17-160,459,078.15
其他综合收益21,559.4611,919.84-9,917.824,068
综合收益总额-44,099,957.95-201,370,690.55-193,467,671.99-160,455,010.15
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,130,068,171.691,222,617,812.371,019,445,815.41,063,499,271.46
非流动资产合计593,674,627.65589,520,367.36986,182,222.26993,674,051.8
资产总计1,723,742,799.341,812,138,179.732,005,628,037.662,057,173,323.26
流动负债合计415,284,493.23395,204,569.94476,222,583.53473,455,305.41
非流动负债合计211,246,867.16275,622,212.89380,191,038.67401,490,940.55
负债合计626,531,360.39670,826,782.83856,413,622.2874,946,245.96
归属于母公司股东权益合计1,097,211,438.951,141,311,396.91,149,214,415.461,182,227,077.3
股东权益合计1,097,211,438.951,141,311,396.91,149,214,415.461,182,227,077.3
负债和股东权益合计1,723,742,799.341,812,138,179.732,005,628,037.662,057,173,323.26
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计27,612,104.41191,548,462.53131,499,749.8488,475,130.1
经营活动现金流出小计76,281,432.49364,064,774.58265,424,672.34177,666,628.32
经营活动产生的现金流量净额-48,669,328.08-172,516,312.05-133,924,922.5-89,191,498.22
投资活动现金流入小计856,036,498.343,441,147,987.752,454,419,998.831,781,984,615.63
投资活动现金流出小计793,652,130.913,631,929,445.542,822,987,050.271,907,634,776.89
投资活动产生的现金流量净额62,384,367.43-190,781,457.79-368,567,051.44-125,650,161.26
筹资活动现金流入小计39,000,000393,926,406.17324,609,468.99281,928,311.25
筹资活动现金流出小计83,419,439.56308,313,707.75274,795,091.37218,949,984.33
筹资活动产生的现金流量净额-44,419,439.5685,612,698.4249,814,377.6262,978,326.92
汇率变动对现金及现金等价物的影响-4,608.064,532.3313,432.766,475.11
现金及现金等价物净增加额-30,709,008.27-277,680,539.09-452,664,163.56-151,856,857.45
期末现金及现金等价物余额218,010,949.55248,719,957.8273,736,333.35374,543,639.46
最新报告期:2025-05-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国盛证券张金洋,胡偌碧,陈欣黎-0.49-0.32-0.472025-05-08
TOP↑